Recombinant Human LEDGF p52 Protein, CF

Recombinant Human LEDGF p52 Protein, CF Summary

Product Specifications

Product Datasheets

Carrier Free

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

Background: LEDGF

Lens epithelium-derived growth factor (LEDGF; also PC4 and SFRS1-interacting protein, PSIP, transcriptional co-activator p75/p52, and dense fine speckles 70 kDa protein) is a ubiquitously expressed, 75 kDa member of the hepatoma-derived growth factor (HDGF) family of proteins (1). Human LEDGF is 530 amino acids (aa) in length. LEDGF contains a PWWP domain (aa 1 - 64), a nuclear localization signal (aa 146 - 156), two coiled-coil regions (aa 306 - 334 and 371 - 395), and four helical regions (aa 347 - 362, 370 - 381, 394 - 403 and 410 - 425). In addition, there are multiple serine and threonine residues that are sites of potential phosphorylation. The protein is highly charged, with lysine, arginine, glutamate, and aspartate comprising 39% of the total residues (1). Two splicing variants produce a second isoform known as p52. p52 has an 8 aa substitution corresponding to aa 326 - 333 of LEDGF, and a deletion of the final 197 aa found in LEDGF. Human LEDGF shares 92% aa sequence identity with mouse and rat LEDGF. LEDGF functions as a transcriptional co-activator that is involved in neuroepithelial stem cell differentiation and neurogenesis (2). It is also a survival factor that is inducible by oxidative stress and protects cells from various stresses by upregulating stress-responsive genes (3 - 4). For example, TNF-alpha elevates the expression of LEDGF, which increases the expression of endogenous gamma -GHS-HS, the catalytic subunit of the regulating enzyme in GSH biosynthesis that constitutes a protective mechanism in limiting oxidative stress induced by inflammatory cytokines (3). LEDGF is also a major autoantigen in atopic dermatitis and other inflammatory conditions involving dysregulated apoptosis (5 - 7). Anti-LEDGF autoantibodies have been shown to have cytotoxic activity, suggesting their involvement in pathogenesis (6). In apoptotic cells, caspases cleave this protein at three sites within functionally important domains, generating two fragments of 65 and 58 kDa (6). Caspase cleavage abolishes the survival function of LEDGF and may generate variants of the protein that enhance apoptosis (6). LEDGF has also been shown to interact with lentiviral integrase (IN) proteins, including HIV-1 IN, directly, determining their nuclear localization and their tight association with nuclear DNA (8). This prevents proteosomal degradation of these proteins (8).

Related Research Areas

• Stem Cell Transcription Factor Regulators
• Transcriptional Co-Activators